Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1174372

registered interest
date	29/01/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Smoking: Public Buildings
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether the Government plans to bring forward legislative proposals to ban smoking at the entrances of public buildings.
tabling member constituency	Bolton South East
tabling member printed	Yasmin Qureshi
uin	9642
answer	answer is ministerial correction date of answer 07/02/2020 answer text <p>The Government has a track record of reducing the harm caused by tobacco. The United Kingdom is a world leader and has been rated the best in Europe on tobacco control by independent experts.</p><p>The Health Act 2006 and the Smoke-free (Premises and Enforcement) Regulations 2006 made it illegal to smoke in public enclosed or substantially enclosed areas and workplaces. We support development and implementation of smoke-free policies locally in and around public premises.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 07/02/2020 11:12:06 answering member 4380 label Biography information for Jo Churchill
tabling member	3924 label Biography information for Yasmin Qureshi

1170706

registered interest
date	14/01/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Smoking: Public Buildings
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of bringing forward legislative proposals to ban smoking at the entrances of public buildings.
tabling member constituency	Bolton South East
tabling member printed	Yasmin Qureshi
uin	3162
answer	answer is ministerial correction date of answer 22/01/2020 answer text <p>The Government has a track record of reducing the harm caused by tobacco and the United Kingdom is considered a world leader in tobacco control. We have been rated the best in Europe on tobacco control by independent experts. However, we are not complacent: tobacco legislation is kept under review to ensure it continues to protect the public’s health.</p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 22/01/2020 14:22:43 answering member 4380 label Biography information for Jo Churchill
tabling member	3924 label Biography information for Yasmin Qureshi

1111113

registered interest
date	10/04/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pregnancy Tests
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 9 April 2019 to Question 239926 on Pregnancy Tests, for what reason previous studies were not considered robust; and what the extensive limitations were.
tabling member constituency	Bolton South East
tabling member printed	Yasmin Qureshi
uin	243382
answer	answer is ministerial correction date of answer 15/04/2019 answer text <p>The Commission on Human Medicines Expert Working Group on Hormone Pregnancy Tests considered that the key limitations of previous studies related to the accuracy of recording of what drug was taken by the women; clarity over the timing of administration during pregnancy; adjustment for confounding factors; selection of controls; and the statistical methodology.</p><p> </p><p>The Expert Group used a quality scoring system to evaluate the quality of each individual study according to a set of seven pre-defined quality criteria. The criteria and score agreed by the Expert Working Group for each study are published in Annex 27 of the final report.</p><p> </p><p>The criteria for selecting members of the Expert Working Group were based on the expertise needed to evaluate all aspects of the questions before the Group and the types of data that would need to be assessed. Membership included those with expertise in pharmaco-epidemiology, including perinatal and paediatric epidemiology, medical statistics, embryology, clinical genetics, gynaecology, reproductive endocrinology, toxicology and pharmacology.</p><p> </p><p>The process for selecting members was in line with established policy for expert groups of the Commission on Human Medicines, with the nominations being agreed by the Commission and endorsed by Ministers.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price grouped question UIN 243383 question first answered 15/04/2019 14:23:24 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	3924 label Biography information for Yasmin Qureshi

1111114

registered interest
date	10/04/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Hormone Pregnancy Tests Expert Working Group
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the criteria were for selecting members of the Expert Working Group for Hormone Pregnancy Tests.
tabling member constituency	Bolton South East
tabling member printed	Yasmin Qureshi
uin	243383
answer	answer is ministerial correction date of answer 15/04/2019 answer text <p>The Commission on Human Medicines Expert Working Group on Hormone Pregnancy Tests considered that the key limitations of previous studies related to the accuracy of recording of what drug was taken by the women; clarity over the timing of administration during pregnancy; adjustment for confounding factors; selection of controls; and the statistical methodology.</p><p> </p><p>The Expert Group used a quality scoring system to evaluate the quality of each individual study according to a set of seven pre-defined quality criteria. The criteria and score agreed by the Expert Working Group for each study are published in Annex 27 of the final report.</p><p> </p><p>The criteria for selecting members of the Expert Working Group were based on the expertise needed to evaluate all aspects of the questions before the Group and the types of data that would need to be assessed. Membership included those with expertise in pharmaco-epidemiology, including perinatal and paediatric epidemiology, medical statistics, embryology, clinical genetics, gynaecology, reproductive endocrinology, toxicology and pharmacology.</p><p> </p><p>The process for selecting members was in line with established policy for expert groups of the Commission on Human Medicines, with the nominations being agreed by the Commission and endorsed by Ministers.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price grouped question UIN 243382 question first answered 15/04/2019 14:23:24 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	3924 label Biography information for Yasmin Qureshi

1109206

registered interest
date	02/04/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pregnancy Tests
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether a meta-analysis was carried out as part of the Commission on Human Medicines' Expert Working Group review into Hormone Pregnancy Tests.
tabling member constituency	Bolton South East
tabling member printed	Yasmin Qureshi
uin	239925
answer	answer is ministerial correction date of answer 09/04/2019 answer text <p>The Commission on Human Medicines’ Expert Working Group (EWG) review into Hormone Pregnancy Tests (HPTs) was comprehensive, scientifically robust and independent. Based on the totality of the data, the review concluded the available scientific evidence did not support a causal association between the use of HPTs during early pregnancy and birth defects or miscarriage. All evidence considered by the EWG has been published online.</p><p> </p><p>The EWG did not undertake a meta-analysis as part of the review. The EWG examined a large number of epidemiological studies, many of which were conducted under different designs. The EWG considered whether meta-analysis was possible and ultimately concluded that because the studies were so different such an analysis would not be informative. Meta-analysis was also not considered appropriate because the studies were not sufficiently robust and suffered from extensive limitations.</p><p> </p><p>The EWG comprised independent experts from a wide range of relevant specialisms and its report was further scrutinised by the Commission on Human Medicines, the Government’s independent scientific advisory body on the safety of medicines. There are no plans for further peer review of the report. The Government is committed to reviewing any important new evidence that arises.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price grouped question UIN 239926 question first answered 09/04/2019 11:23:15 answering member 4065 label Biography information for Dame Jackie Doyle-Price previous answer version 112745 answering member constituency Thurrock answering member printed Jackie Doyle-Price answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	3924 label Biography information for Yasmin Qureshi

1109215

registered interest
date	02/04/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pregnancy Tests
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans his Department has for peer review the report of the Commission on Human Medicines Expert Working Group on Hormone Pregnancy Tests.
tabling member constituency	Bolton South East
tabling member printed	Yasmin Qureshi
uin	239926
answer	answer is ministerial correction date of answer 09/04/2019 answer text <p>The Commission on Human Medicines’ Expert Working Group (EWG) review into Hormone Pregnancy Tests (HPTs) was comprehensive, scientifically robust and independent. Based on the totality of the data, the review concluded the available scientific evidence did not support a causal association between the use of HPTs during early pregnancy and birth defects or miscarriage. All evidence considered by the EWG has been published online.</p><p> </p><p>The EWG did not undertake a meta-analysis as part of the review. The EWG examined a large number of epidemiological studies, many of which were conducted under different designs. The EWG considered whether meta-analysis was possible and ultimately concluded that because the studies were so different such an analysis would not be informative. Meta-analysis was also not considered appropriate because the studies were not sufficiently robust and suffered from extensive limitations.</p><p> </p><p>The EWG comprised independent experts from a wide range of relevant specialisms and its report was further scrutinised by the Commission on Human Medicines, the Government’s independent scientific advisory body on the safety of medicines. There are no plans for further peer review of the report. The Government is committed to reviewing any important new evidence that arises.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price grouped question UIN 239925 question first answered 09/04/2019 11:23:15 answering member 4065 label Biography information for Dame Jackie Doyle-Price previous answer version 112746 answering member constituency Thurrock answering member printed Jackie Doyle-Price answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	3924 label Biography information for Yasmin Qureshi

1105850

registered interest
date	28/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pregnancy Tests
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how much was spent from the public purse on the Commission on Human Medicines Expert Working Group on Hormone Pregnancy Tests.
tabling member constituency	Bolton South East
tabling member printed	Yasmin Qureshi
uin	238314
answer	answer is ministerial correction date of answer 02/04/2019 answer text <p>The Commission on Human Medicines (CHM) advises health ministers on the safety, efficacy and quality of medicinal products. Expert Working Groups of the CHM are comprised of independent experts who work on a voluntary basis and receive reasonable expenses. The Medicines and Healthcare products Regulatory Agency provide a secretariat function to the CHM and its Expert Working Groups. This is included in Agency costs. The Agency is an Executive Agency of the Department and it is established as a Government trading fund, with its work predominantly funded by fees charged to the industry it regulates.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 02/04/2019 16:08:11 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	3924 label Biography information for Yasmin Qureshi

1105699

registered interest
date	27/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pregnancy Tests
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he has taken to ensure the (a) impartiality and (b) independence of panels members on the Commission on Human Medicines’ independent scientific review of the publication by Professor Carl Heneghan into hormone pregnancy tests.
tabling member constituency	Bolton South East
tabling member printed	Yasmin Qureshi
uin	237673
answer	answer is ministerial correction date of answer 04/04/2019 answer text <p>Since publication of the report of the Commission on Human Medicines Expert Working Group on Hormone Pregnancy Tests (HPTs) the Government has committed to review any important new evidence that arises. In response to publication of the study by Heneghan et al. the Commission on Human Medicines convened an Expert Group to advise on the suitability and robustness of the methodology (including the selection and application of the data quality score) and any clinical implications.</p><p> </p><p>To ensure impartiality none of the members of the Group was involved in the previous review by the Expert Working Group on HPTs. A specific conflict of interest policy was developed and all participants were required to complete and sign a declaration of interests form. Participants were asked to declare personal or non-personal interests in the companies who marketed HPTs or whose predecessors marketed them, current or previous involvement in any studies or reviews on HPTs, the expression in public of a strong opinion about HPTs or any of the companies that produced them, and direct or indirect involvement with, or peer review of, the publication by Heneghan et al. The conflict of interest policy and declarations of participants will be made public in due course.</p><p> </p><p>For complete transparency the meeting was observed by the Chair of the Association for Children Damaged by HPTs, an advocate for those affected by thalidomide, a Lay representative and a representative from the Independent Medicines and Medical Devices Safety Review.</p><p> </p><p>In parallel, the European Medicines Agency is conducting an independent review of the publication by Heneghan et al. Both reviews are ongoing, and we expect the conclusions to be made public within a month of their completion, likely to be May 2019.</p><p> </p> answering member constituency Thurrock answering member printed Jackie Doyle-Price grouped question UIN 237674 question first answered 04/04/2019 13:11:53 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	3924 label Biography information for Yasmin Qureshi

1105733

registered interest
date	27/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pregnancy Tests
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the timetable is for the publication of the findings of the Commission on Human Medicines’ independent scientific review of the publication by Professor Carl Heneghan into hormone pregnancy tests.
tabling member constituency	Bolton South East
tabling member printed	Yasmin Qureshi
uin	237674
answer	answer is ministerial correction date of answer 04/04/2019 answer text <p>Since publication of the report of the Commission on Human Medicines Expert Working Group on Hormone Pregnancy Tests (HPTs) the Government has committed to review any important new evidence that arises. In response to publication of the study by Heneghan et al. the Commission on Human Medicines convened an Expert Group to advise on the suitability and robustness of the methodology (including the selection and application of the data quality score) and any clinical implications.</p><p> </p><p>To ensure impartiality none of the members of the Group was involved in the previous review by the Expert Working Group on HPTs. A specific conflict of interest policy was developed and all participants were required to complete and sign a declaration of interests form. Participants were asked to declare personal or non-personal interests in the companies who marketed HPTs or whose predecessors marketed them, current or previous involvement in any studies or reviews on HPTs, the expression in public of a strong opinion about HPTs or any of the companies that produced them, and direct or indirect involvement with, or peer review of, the publication by Heneghan et al. The conflict of interest policy and declarations of participants will be made public in due course.</p><p> </p><p>For complete transparency the meeting was observed by the Chair of the Association for Children Damaged by HPTs, an advocate for those affected by thalidomide, a Lay representative and a representative from the Independent Medicines and Medical Devices Safety Review.</p><p> </p><p>In parallel, the European Medicines Agency is conducting an independent review of the publication by Heneghan et al. Both reviews are ongoing, and we expect the conclusions to be made public within a month of their completion, likely to be May 2019.</p><p> </p> answering member constituency Thurrock answering member printed Jackie Doyle-Price grouped question UIN 237673 question first answered 04/04/2019 13:11:53 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	3924 label Biography information for Yasmin Qureshi

1064025

registered interest
date	19/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Dementia
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the report of the Alzheimer's Society entitled Dementia – the true cost: Fixing the care crisis, published in May 2018, whether the Government plans to (a) cover the extra health charges that dementia patients accrue as a result of their condition and (b) ensure that everyone with dementia has a care navigator to support access to timely, preventative and integrated support.
tabling member constituency	Bolton South East
tabling member printed	Yasmin Qureshi
uin	223223
answer	answer is ministerial correction date of answer 27/02/2019 answer text <p>The Green Paper on adult social care will bring forward proposals to ensure that all adults, including those living with dementia, receive high quality care whenever they need it. It will also bring forward ideas for including an element of risk pooling in the system, which will help to protect people from the highest costs.</p><p> </p><p>We remain committed to delivering the Challenge on Dementia 2020 in full to make England the best country in the world for dementia care by 2020. The March 2016 implementation plan details how the commitments in the Challenge, across four core themes of risk reduction, health and care, awareness and social action, and research will be met.</p><p> </p><p>The Implementation Plan envisages general practitioners (GPs) playing a leading role in ensuring coordination and continuity of care for people with dementia. We have recently undertaken a review of our implementation plan to reflect on what has been achieved so far and what more we need to do to achieve our goals by 2020. As a result of that we will be reviewing the role of GPs and whether they remain the staff group best placed to lead on care coordination in all cases.</p><p> </p><p>In addition, the NHS Long Term Plan commits to better support for people with dementia in the community and ongoing close work with the voluntary sector, for example supporting Alzheimer’s Society’s dementia connect programme.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 27/02/2019 11:12:07 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	3924 label Biography information for Yasmin Qureshi